Sopharma Trading AD (BUL:SFT)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 3.140
+0.020 (0.64%)
At close: Oct 2, 2026
Sopharma Trading AD Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,244 | 1,167 | 995.4 | 855.56 | 755.77 | 683.08 |
Other Revenue | 8.23 | 6.93 | 4.82 | 2.59 | 2.18 | - |
| 1,252 | 1,173 | 1,000 | 858.14 | 757.95 | 683.08 | |
Revenue Growth | 13.12% | 17.32% | 16.56% | 13.22% | 10.96% | 15.58% |
Cost of Revenue | 1,087 | 1,013 | 872.2 | 757.93 | 669.96 | 610.29 |
Gross Profit | 165.67 | 160.48 | 128.01 | 100.21 | 87.99 | 72.79 |
Selling, General & Admin | 101.35 | 93.4 | 76.41 | 59.09 | 51.49 | 49.99 |
Other Operating Expenses | 3.69 | 3.26 | 1.89 | 1.85 | 0.75 | -0.15 |
Operating Expenses | 129.32 | 119.35 | 97.23 | 77.35 | 67.61 | 64.58 |
Operating Income | 36.36 | 41.13 | 30.78 | 22.86 | 20.38 | 8.21 |
Interest Expense | -6.75 | -6.36 | -5 | -4.31 | -2.65 | -2.74 |
Interest & Investment Income | 0.48 | 0.53 | 0.56 | 0.24 | 0.36 | 1.08 |
Earnings From Equity Investments | -0.02 | -0.03 | -0 | - | - | - |
Currency Exchange Gain (Loss) | 0.12 | 0.63 | -2.29 | -0.07 | -0.06 | -0.08 |
Other Non Operating Income (Expenses) | -0.86 | -0.34 | -0.36 | -1.34 | -0.89 | -0.49 |
EBT Excluding Unusual Items | 29.34 | 35.56 | 23.69 | 17.38 | 17.15 | 5.96 |
Merger & Restructuring Charges | - | - | -0.06 | - | - | - |
Impairment of Goodwill | - | - | - | - | -6.81 | - |
Gain (Loss) on Sale of Assets | 0.26 | 0.29 | 0.29 | 0.11 | 0.23 | 0.15 |
Asset Writedown | -0.04 | -0.05 | - | - | -4.23 | -1.35 |
Other Unusual Items | - | - | 0.17 | - | - | 0.06 |
Pretax Income | 29.55 | 35.8 | 24.1 | 17.49 | 6.33 | 4.83 |
Income Tax Expense | 5.38 | 5.93 | 3.7 | 2.56 | 1.69 | 0.71 |
Earnings From Continuing Operations | 24.17 | 29.87 | 20.39 | 14.93 | 4.64 | 4.12 |
Minority Interest in Earnings | -0.08 | -0.16 | 0.25 | - | - | - |
Net Income | 24.09 | 29.71 | 20.64 | 14.93 | 4.64 | 4.12 |
Net Income to Common | 24.09 | 29.71 | 20.64 | 14.93 | 4.64 | 4.12 |
Net Income Growth | -18.78% | 43.91% | 38.23% | 221.74% | 12.75% | -29.83% |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Change | 0.17% | -0.67% | -0.13% | - | - | - |
EPS (Basic) | 0.71 | 0.87 | 0.60 | 0.44 | 0.14 | 0.12 |
EPS (Diluted) | 0.71 | 0.87 | 0.60 | 0.44 | 0.14 | 0.12 |
EPS Growth | -18.92% | 44.88% | 38.41% | 221.74% | 12.75% | -29.83% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 23.51 | -10.77 | 28.01 | 19.24 | 6.56 | -92.24 |
Free Cash Flow Per Share | 0.69 | -0.32 | 0.82 | 0.56 | 0.19 | -2.69 |
Gross Margin | 13.23% | 13.68% | 12.80% | 11.68% | 11.61% | 10.66% |
Operating Margin | 2.90% | 3.50% | 3.08% | 2.66% | 2.69% | 1.20% |
Profit Margin | 1.92% | 2.53% | 2.06% | 1.74% | 0.61% | 0.60% |
Free Cash Flow Margin | 1.88% | -0.92% | 2.80% | 2.24% | 0.87% | -13.50% |
EBITDA | 39.17 | 50.01 | 38.08 | 29.39 | 34.36 | 14.36 |
EBITDA Margin | 3.13% | 4.26% | 3.81% | 3.43% | 4.53% | 2.10% |
D&A For EBITDA | 2.82 | 8.88 | 7.3 | 6.53 | 13.97 | 6.15 |
EBIT | 36.36 | 41.13 | 30.78 | 22.86 | 20.38 | 8.21 |
EBIT Margin | 2.90% | 3.50% | 3.08% | 2.66% | 2.69% | 1.20% |
Effective Tax Rate | 18.21% | 16.56% | 15.37% | 14.62% | 26.73% | 14.70% |
Advertising Expenses | - | 5.53 | 5.75 | 3.35 | 2.12 | 1.77 |